Inactive Instrument

All News OXiGENE Inc Nasdaq

Equities

US6918284042

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 12	Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 12	CI
Oncotelic Therapeutics, Inc. - Linkage of Cancer and Lupus in Gliomas Patients	Mar. 26	AQ
Linkage of Cancer and Lupus in Gliomas Patients	Mar. 25	AQ
Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	Mar. 25	CI
Invitation to Participate in STOP-PC Clinical Trial	Mar. 04	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024 (Updated)	Feb. 21	AQ
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients	Jan. 16	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	Dec. 22	AQ
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant	Dec. 18	AQ
Oncotelic Therapeutics Announces CEO to Discuss Proprietary AI Technology at Ibero-American Chatbot Summit	Nov. 29	AQ
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.	Nov. 28	AQ
Earnings Flash (OTLC) ONCOTELIC THERAPEUTICS Posts Q3 Revenue $70,000	Nov. 15	MT
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results	Nov. 15	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Oncotelic Therapeutics, Inc. announces tranche update	23-10-23	CI
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	23-08-28	AQ
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	23-08-25	AQ
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer	23-08-23	AQ
Oncotelic Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI
Four Potentially Undervalued OTC Stocks (DDDX, OTLC, AABB, UNRV)	23-06-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News OXiGENE Inc Nasdaq

Equities

US6918284042

All News

Filters